Atlas Trials

Urodynamic and Clinical Efficacy of Mirabegron for Neurogenic Bladder Patients

Clinical trial NCT02044510 · TERMINATED

Trial details

NCT number
NCT02044510
Sponsor
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Status
TERMINATED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Urinary Bladder, Neurogenic
Start date
2014-07-01
Primary completion
2018-01-01
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.